The combination of hydroxychloroquine and zinc has been proposed as a potential therapeutic regimen for COVID-19 due to the synergistic effects of the two agents.
hcq Zinc has antiviral properties and may enhance the intracellular activity of hydroxychloroquine against SARS-CoV-2. While preliminary data are promising, larger clinical trials are needed to evaluate the efficacy and safety of this combination therapy in patients with COVID-19.